Cargando…
Relapse of membranous nephropathy with cancer immunotherapy
Advances in monoclonal antibody technology have enabled the application of engineered antibodies to interfere with specific immune pathways. Checkpoint inhibitors have shown promising results in treating certain cancers by employing patients’ own immune systems to attack cancer cells. Checkpoint inh...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857825/ https://www.ncbi.nlm.nih.gov/pubmed/33564446 http://dx.doi.org/10.1093/ckj/sfz074 |